Hepatitis B or C serologies consistent with past or current infections
Patients with clinically active hepatitis A, B, or C infections are not eligible\r\n* Note: patients with a history of hepatitis may be eligible if they have a normal titer; such cases should be approved by the study principal investigator (PI)
Active hepatitis viral infections
Chronic infections (e.g., hepatitis B or C, tuberculosis)
COHORT : HORMONE RECEPTOR POSITIVE BREAST CANCER: Patients who have known active hepatitis B, or hepatitis C infections
COHORT : TRIPLE NEGATIVE BREAST CANCER: Patients who have known active hepatitis B, or hepatitis C infections
Other active infections aside from hepatitis
Active infections requiring therapy, including HIV, hepatitis
Subject with known active HIV, Hepatitis B, or Hepatitis C infections.
They have active infections such as hepatitis or fungal infections.
Known systemic infections including, but not limited to hepatitis B or C, or HIV
History of, or presently active or chronic viral infections (i.e. zoster or hepatitis)
Active hepatitis or other active infections
Known HIV and/or Hepatitis B or C infections
Active and uncontrolled infections, including hepatitis B or C
Patients with any active hepatitis infections.
Known serious infections, including a history of active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV); screening for these infections is not required for study enrollment
Patients with known active treatment for hepatitis B and C infections
Uncontrolled significant active infections, except Hepatitis B (HBV) or Hepatitis C (HCV)
Patients with known active treatment for hepatitis B and C infections
Clinically active hepatitis A, B, or C infections
Patients with active treatment for active hepatitis B and C infections
